At a glance
- Originator Servier
- Class Neuroprotectants
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stroke
Most Recent Events
- 30 Oct 2006 Discontinued - Preclinical for Stroke in France (unspecified route)
- 19 Sep 2002 Preclinical trials in Stroke in France (unspecified route)